Breathing in xenon gas could reveal hidden lung damage
NCT ID NCT05914506
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether a special MRI scan using xenon gas can spot early signs of lung scarring and heart strain in people with progressive lung fibrosis. About 30 adults already on anti-fibrotic medication will be scanned and followed over time. The goal is to see if this imaging method can detect disease activity and predict who will worsen, potentially leading to earlier and better treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROSING INTERSTITIAL LUNG DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aarhus University, Department of Clinical Medicine, MR Research Centre
Aarhus, 8200, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Frailty and muscle loss may predict outcomes in lung scarring patients
- New pill aims to halt lung scarring in thousands
- Hope for kids with scarred lungs: new drug trial launches
- New hope for kids with rare lung disease: long-term drug safety trial completed
- New pill aims to slow lung damage in scarring disease